Impact of immunosuppressive regimen on cardiovascular risk factors in kidney transplant recipients.
Boucher
A
A
Department of Nephrology, Hôpital Maisonneuve-Rosemont, Université de Montréal, 5415 boul l'Assumption, Montreal, Québec, Canada H1T 2M4.
Masse
M
M
Lauzon
L
L
Morin
M
M
Dandavino
R
R
D002318:Cardiovascular Diseases / Q000453:epidemiology*; D003404:Creatinine / Q000097:blood; D016572:Cyclosporine / Q000009:adverse effects; D003920:Diabetes Mellitus / Q000453:epidemiology; D004359:Drug Therapy, Combination; D005260:Female; D006801:Humans; D006973:Hypertension / Q000453:epidemiology; D007166:Immunosuppressive Agents / Q000009:adverse effects*; D016030:Kidney Transplantation / Q000276:immunology / Q000502:physiology*; D008297:Male; D011183:Postoperative Complications / Q000453:epidemiology*; D012189:Retrospective Studies; D012307:Risk Factors; D012727:Sex Characteristics; D016559:Tacrolimus / Q000009:adverse effects
D007166:Immunosuppressive Agents; D016572:Cyclosporine; D003404:Creatinine; D016559:Tacrolimus